Clinical Trials Logo

Filter by:
NCT ID: NCT00886769 Terminated - Clinical trials for Systemic Juvenile Idiopathic Arthritis

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)

ß-SPECIFIC 1
Start date: July 2009
Phase: Phase 3
Study type: Interventional

This study assessed the initial efficacy and safety of canakinumab over a 4 week period in patients with systemic juvenile idiopathic arthritis (SJIA) having a flare. Response to treatment will be according to the adapted American College of Rheumatology(ACR)Pediatric 30 criteria at Day 15.

NCT ID: NCT00885677 Terminated - Heart Failure Clinical Trials

MOnitoring REsynchronization deviCes and cARdiac patiEnts

MORE-CARE
Start date: June 2009
Phase: N/A
Study type: Interventional

The objective of this study is to compare two different strategies of disease management in heart failure patients treated with cardiac resynchronization therapy devices 1. Remote monitoring with CareLink Network System 2. Standard management of the disease by means of scheduled routine in-patient follow-ups; and to demonstrate that the remote monitoring strategy is superior to the standard strategy, both in terms of clinical effectiveness and total healthcare system utilization.

NCT ID: NCT00884390 Terminated - Hemophilia A Clinical Trials

Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings

Start date: May 2009
Phase: Phase 4
Study type: Interventional

The study will be investigating safety in patients who switch to ReFacto AF from ReFacto and other Factor VIII products.

NCT ID: NCT00883116 Terminated - Endometrial Cancer Clinical Trials

A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer

IXAMPLE2
Start date: August 2009
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to investigate whether administration of ixabepilone results in superior outcome as assessed by overall survival compared with that achieved with standard chemotherapy (paclitaxel or doxorubicin) in women with advanced endometrial cancer that has progressed following first-line chemotherapy.

NCT ID: NCT00878891 Terminated - Diabetes Clinical Trials

Real-time Continuous Glucose Monitoring in Diabetic Cardiothoracic Surgery Patients

MARGE
Start date: April 2009
Phase: N/A
Study type: Interventional

An increased risk of adverse outcome is noted for diabetic patients admitted in surgery intensive care units (ICU). Tight glycemic control with intensive insulin therapy dramatically reduces in-hospital mortality and adverse outcome. Devices recording continuously interstitial glucose monitoring (CGM) may be an aid in patients of ICU in whom normoglycemia become a target. The mini-invasive device (Glucoday®) should provide real-time glucose concentrations in order to quickly adjust insulin infusion rates. The objective of MARGE study is to compare percent of time in normoglycemia based on conventional monitoring (discontinuous glucose monitoring) and Glucoday to conventional monitoring alone. The MARGE study is a multicenter (2 centers), randomized, single blind trial. Several studies have shown that hyperglycemia is associated with poor outcomes in hospitalized patients. Postoperative glucose levels are a significant predictor of infection rates after cardiac surgery and death rate. Based on these observational studies, a randomized controlled intervention trial in surgical ICU patients demonstrated that intensive insulin therapy reduced the overall in-hospital mortality by 34 % and stream infection by 46 %. Using continuous glycemic monitoring (CGM) it has been shown that intensive insulin therapy based on discontinuous glucose monitoring revealed that normoglycemia is achieved only 22 % of time. The researchers' aim is to determine if real time CGM with a new generation mini invasive device, Glucoday® S, would allow quickly adjusting insulin infusions rates according to interstitial glucose levels and decreasing both hyperglycemic and hypoglycemic excursions. This study will further investigate whether application of real time CGM to titrate insulin therapy to target glycemia in a tight range (80-110 mg/dl) can improve diabetic patient outcome after coronary artery bypass grafting (CABG).

NCT ID: NCT00878202 Terminated - Heart Failure Clinical Trials

Therapeutic Education by Telemedicine in Chronic Heart Failure

SEDIC
Start date: March 2009
Phase: Phase 4
Study type: Interventional

The purpose of the SEDIC study is to test a home based heart failure patient clinical follow-up and therapeutic education using telemedicine. This educational follow-up is based on an interactive information system (SCAD) including a touch screen personal computer for heart failure patient at home. An interactive algorithm has been developed to allow a self management teaching to the patient.Furthermore, a specialized nurse provide a clinical data follow-up.

NCT ID: NCT00878046 Terminated - Osteoarthritis Clinical Trials

Multi-centre Study to Assess Long-term Safety and Efficacy of the Silentâ„¢ Hip Prosthesis in Primary THR

Start date: May 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the Silentâ„¢ hip is effective in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments. A subset of patients will undergo scans to allow the bone mineral density of the bone surrounding the implant to be monitored

NCT ID: NCT00877318 Terminated - Heart Failure Clinical Trials

Cardiac Rehabilitation of Heart Failure Patients by Telemedicine

READ
Start date: March 2009
Phase: Phase 4
Study type: Interventional

The purpose of the READ study is to compare the continuation of the cardiac rehabilitation at home with clinical follow-up, therapeutic education, and advice on the training at the stamina, via telemedicine with the classic strategy in day hospital.

NCT ID: NCT00875004 Terminated - Anemia Clinical Trials

Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors

PLATON
Start date: December 7, 2007
Phase: N/A
Study type: Interventional

RATIONALE: Epoetin beta may cause the body to make more red blood cells and may prevent or reduce side effects in patients undergoing chemotherapy for solid tumors. PURPOSE: This clinical trial is studying how well epoetin beta works in patients undergoing chemotherapy for solid tumors.

NCT ID: NCT00873470 Terminated - Clinical trials for Wolff-Parkinson-White Syndrome

Wolff-Parkinson-White Syndrome Anterograde Refractory Period of Accessory Duct

WPW
Start date: February 2009
Phase: N/A
Study type: Interventional

The study consists of the realization of a new esophageal stimulation for patients already stimulated 10 years ago. The investigators would like to make a long term evaluation of the evolution of anterograde effective refractory period of accessory duct in the WPW syndrome. This study will be realized by esophageal stimulation.